Submitted by Anonymous (not verified) on 28 August 2023 - 9:37
Opinion/decision on a Paediatric investigation plan (PIP): Remibrutinib, decision type: , therapeutic area: , PIP number: P/0345/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Remibrutinib, decision type: , therapeutic area: , PIP number: P/0345/2022